Zomedica (ZOM) said Tuesday it struck a deal to market Cresilon's Vetigel hemostatic gel product line on an exclusive basis in the US and on a non-exclusive basis in other regions.

Under the license and supply agreement, Zomedica said it will assume responsibility for supplying US customers and will collaborate with Cresilon to support customers outside the country.

Vetigel is a plant-based formula to stop bleeding when applied to the source, the veterinary healthcare company said.